R&D Why are clinical trials struggling with diversity? In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative.
Patients To increase clinical trial diversity, build trust in communi... After a long period of not much change, clinical trials are undergoing several massive shifts.
R&D Examining COVID’s impact on clinical research participant di... The clinical research industry has long struggled with participant diversity.
News Clarify Health’s new offering shows one way tech can help im... The last three years in pharma have seen a growing awareness of and dissatisfaction with a trend that has plagued the industry for its whole life: Nondiverse and unrepresentative clinical t
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.